Matches in Wikidata for { <http://www.wikidata.org/entity/Q91852767> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- Q91852767 description "2019 թվականի դեկտեմբերի 10-ին հրատարակված գիտական հոդված" @default.
- Q91852767 description "article scientifique publié en 2019" @default.
- Q91852767 description "artículu científicu espublizáu n'avientu de 2019" @default.
- Q91852767 description "scientific article published on 10 December 2019" @default.
- Q91852767 description "wetenschappelijk artikel" @default.
- Q91852767 description "наукова стаття, опублікована 10 грудня 2019" @default.
- Q91852767 name "First-in-Man Phase I Trial of the Selective MET Inhibitor Tepotinib in Patients with Advanced Solid Tumors" @default.
- Q91852767 name "First-in-Man Phase I Trial of the Selective MET Inhibitor Tepotinib in Patients with Advanced Solid Tumors" @default.
- Q91852767 type Item @default.
- Q91852767 label "First-in-Man Phase I Trial of the Selective MET Inhibitor Tepotinib in Patients with Advanced Solid Tumors" @default.
- Q91852767 label "First-in-Man Phase I Trial of the Selective MET Inhibitor Tepotinib in Patients with Advanced Solid Tumors" @default.
- Q91852767 prefLabel "First-in-Man Phase I Trial of the Selective MET Inhibitor Tepotinib in Patients with Advanced Solid Tumors" @default.
- Q91852767 prefLabel "First-in-Man Phase I Trial of the Selective MET Inhibitor Tepotinib in Patients with Advanced Solid Tumors" @default.
- Q91852767 P1433 Q91852767-4AE926D4-8604-4B3E-9E36-0BEE6045816B @default.
- Q91852767 P1476 Q91852767-07DD347C-36E7-4D9F-BCD2-425B9FE5BF20 @default.
- Q91852767 P2093 Q91852767-02F089F3-955C-49AA-A3DD-9EA4FA926F40 @default.
- Q91852767 P2093 Q91852767-10AFD5A2-E3C2-4E61-9DE2-AD3EBB8A6548 @default.
- Q91852767 P2093 Q91852767-1848FA47-11B9-42E0-8B67-FF2D3B004B64 @default.
- Q91852767 P2093 Q91852767-39096D78-3EC5-4625-B7B5-71AA84B42A16 @default.
- Q91852767 P2093 Q91852767-40333E5A-DADB-4CC4-81D5-B1467857FF4A @default.
- Q91852767 P2093 Q91852767-43C0041F-A55B-4BD1-B4FD-197E04084479 @default.
- Q91852767 P2093 Q91852767-47F7F212-8AC0-462C-9C84-F1A4E2E800B5 @default.
- Q91852767 P2093 Q91852767-5F5AF978-982B-43D7-8C12-2906E9BD25C3 @default.
- Q91852767 P2093 Q91852767-745D17AB-D644-4BA8-90D8-CE2027D683B8 @default.
- Q91852767 P2093 Q91852767-7564726B-89AE-41DF-80E9-D35D8A7C4F50 @default.
- Q91852767 P2093 Q91852767-8CB4CC0C-F905-4899-A291-04E22231D0A2 @default.
- Q91852767 P2093 Q91852767-9A280C03-ECCE-4D22-9102-41192669967F @default.
- Q91852767 P2093 Q91852767-CB9C791B-5E91-4BE3-B52F-57D394D5CEE4 @default.
- Q91852767 P2093 Q91852767-D9C27A9A-EEDA-45FA-9C25-939F1CE68F12 @default.
- Q91852767 P2093 Q91852767-FD05489A-CD6D-41E0-899E-A73FEB8AB686 @default.
- Q91852767 P304 Q91852767-AE6740AD-3759-433C-8FDB-4ACC1A7D25F0 @default.
- Q91852767 P31 Q91852767-27C4B0D6-CBDB-4202-A630-E15F262BBEA3 @default.
- Q91852767 P356 Q91852767-7240B817-1A17-435D-89C8-0E2C12314D28 @default.
- Q91852767 P433 Q91852767-9CF23935-464D-4238-BC71-0000F9EF5F3A @default.
- Q91852767 P478 Q91852767-0EAE8083-1A2E-4414-B132-71B07F86E045 @default.
- Q91852767 P50 Q91852767-232A1BB4-B325-45E9-ADB0-37772BE9B6C1 @default.
- Q91852767 P50 Q91852767-C8D964E7-02ED-415B-B32F-1804B0845BC6 @default.
- Q91852767 P50 Q91852767-E42F1F27-A650-442C-8C6B-05FC656233C4 @default.
- Q91852767 P577 Q91852767-E3751C72-AA3A-4659-AF4F-526E78D0ABCA @default.
- Q91852767 P698 Q91852767-2D8E40A5-8269-457F-9DD1-2B3AFFC817CF @default.
- Q91852767 P921 Q91852767-78F11948-0AE1-419A-BEA2-949568DF993C @default.
- Q91852767 P356 1078-0432.CCR-19-2860 @default.
- Q91852767 P698 31822497 @default.
- Q91852767 P1433 Q332253 @default.
- Q91852767 P1476 "First-in-Man Phase I Trial of the Selective MET Inhibitor Tepotinib in Patients with Advanced Solid Tumors" @default.
- Q91852767 P2093 "Andreas Johne" @default.
- Q91852767 P2093 "Daniel V Catenacci" @default.
- Q91852767 P2093 "Friedhelm Bladt" @default.
- Q91852767 P2093 "Gerald S Falchook" @default.
- Q91852767 P2093 "Ghazaleh Eskandari" @default.
- Q91852767 P2093 "Hesham M Amin" @default.
- Q91852767 P2093 "Manfred Klevesath" @default.
- Q91852767 P2093 "Manja Friese-Hamim" @default.
- Q91852767 P2093 "Pascal Girard" @default.
- Q91852767 P2093 "Rolf Bruns" @default.
- Q91852767 P2093 "Samer El Bawab" @default.
- Q91852767 P2093 "Sarina A Piha-Paul" @default.
- Q91852767 P2093 "Siqing Fu" @default.
- Q91852767 P2093 "Uz Stammberger" @default.
- Q91852767 P2093 "Wenyuan Xiong" @default.
- Q91852767 P304 "1237-1246" @default.
- Q91852767 P31 Q13442814 @default.
- Q91852767 P356 "10.1158/1078-0432.CCR-19-2860" @default.
- Q91852767 P433 "6" @default.
- Q91852767 P478 "26" @default.
- Q91852767 P50 Q56614941 @default.
- Q91852767 P50 Q73569186 @default.
- Q91852767 P50 Q89171488 @default.
- Q91852767 P577 "2019-12-10T00:00:00Z" @default.
- Q91852767 P698 "31822497" @default.
- Q91852767 P921 Q5452194 @default.